PMID- 31820181 OWN - NLM STAT- MEDLINE DCOM- 20201110 LR - 20221207 IS - 1573-2568 (Electronic) IS - 0163-2116 (Print) IS - 0163-2116 (Linking) VI - 65 IP - 8 DP - 2020 Aug TI - Symptoms Suggestive of Gastroparesis in a Community-Based Cohort of European Americans and African Americans with Type 2 Diabetes Mellitus. PG - 2321-2330 LID - 10.1007/s10620-019-05974-z [doi] AB - BACKGROUND: Although gastroparesis is seen in patients with type 2 diabetes mellitus (T2DM), the prevalence of symptoms suggestive of gastroparesis in patients with T2DM is unknown, particularly among African Americans. AIMS: To determine the prevalence of symptoms associated with gastroparesis in a large community-based population of European Americans and African Americans with T2DM. METHODS: Individuals with T2DM in the Diabetes Heart Study were asked to complete the gastroparesis cardinal symptom index (GCSI) and other GI-related questionnaires. GCSI total score >/= 18 represented moderate or worse symptoms suggestive of gastroparesis. RESULTS: A total of 1253 participants (700 female, 553 male) completed the GCSI: 750 were European American and 503 African American. GCSI scores >/= 18 were recorded in 72 participants: 38 (5%) of European Americans and 34 (7%) of African Americans. The average GCSI was 24.1 in European Americans and 24.6 in African Americans, indicating moderate to severe symptoms. Compared to European Americans with GCSI scores >/= 18, African Americans were younger (59.4 vs. 53.3 years, p = 0.004), had earlier onset of T2DM (46.3 vs. 40.1 years, p = 0.01), higher HbA1c (7.6 vs. 9.1, p = 0.0009), underwent fewer upper endoscopies (55.3% vs. 26.5%, p = 0.02), and had more anxiety and depression (p < 0.001). CONCLUSIONS: Moderate or greater symptoms suggestive of gastroparesis are present in 5-7% of European and African American patients with T2DM in community-based populations. Symptoms suggestive of gastroparesis may be underappreciated in patients with T2DM and account for upper gastrointestinal symptoms, unexplained glycemic control issues, and decreased quality of life. FAU - Brown, Landon K AU - Brown LK AD - Department of Internal Medicine, Wake Forest School of Medicine, 1 Medical Center Blvd, Winston-Salem, NC, 27157, USA. landon.brown526@gmail.com. FAU - Xu, Jianzhao AU - Xu J AD - Department of Biochemistry and Center for Genomics, Wake Forest School of Medicine, 1 Medical Center Blvd, Winston-Salem, NC, 27157, USA. FAU - Freedman, Barry I AU - Freedman BI AD - Section on Nephrology, Wake Forest School of Medicine, 1 Medical Center Blvd, Winston-Salem, NC, 27157, USA. FAU - Hsu, Fang-Chi AU - Hsu FC AD - Department of Biochemistry and Center for Genomics, Wake Forest School of Medicine, 1 Medical Center Blvd, Winston-Salem, NC, 27157, USA. FAU - Bowden, Donald W AU - Bowden DW AD - Department of Biochemistry and Center for Genomics, Wake Forest School of Medicine, 1 Medical Center Blvd, Winston-Salem, NC, 27157, USA. FAU - Koch, Kenneth L AU - Koch KL AD - Section of Gastroenterology, Wake Forest School of Medicine, 1 Medical Center Blvd, Winston-Salem, NC, 27157, USA. LA - eng GR - R01 HL92301 (DWB)/NH/NIH HHS/United States GR - R01 HL67348 (DWB)/NH/NIH HHS/United States GR - R01 HL067348/HL/NHLBI NIH HHS/United States GR - R01 DK071891/DK/NIDDK NIH HHS/United States GR - R01 HL092301/HL/NHLBI NIH HHS/United States GR - R01 DK071891 (BIF)/NH/NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20191209 PL - United States TA - Dig Dis Sci JT - Digestive diseases and sciences JID - 7902782 SB - IM MH - Black or African American/statistics & numerical data MH - Aged MH - Cohort Studies MH - Diabetes Mellitus, Type 2/*complications MH - Female MH - Gastroparesis/*epidemiology/etiology MH - Humans MH - Male MH - Middle Aged MH - North Carolina/epidemiology MH - Prevalence MH - Severity of Illness Index MH - White People/statistics & numerical data PMC - PMC9135394 MID - NIHMS1800781 OTO - NOTNLM OT - Community-based population OT - Gastroparesis OT - Gastroparesis cardinal symptom index OT - Type 2 diabetes mellitus COIS- Conflict of interest All authors have no conflicts of interest or financial disclosures to disclose. EDAT- 2019/12/11 06:00 MHDA- 2020/11/11 06:00 PMCR- 2022/05/26 CRDT- 2019/12/11 06:00 PHST- 2019/03/26 00:00 [received] PHST- 2019/11/22 00:00 [accepted] PHST- 2019/12/11 06:00 [pubmed] PHST- 2020/11/11 06:00 [medline] PHST- 2019/12/11 06:00 [entrez] PHST- 2022/05/26 00:00 [pmc-release] AID - 10.1007/s10620-019-05974-z [pii] AID - 10.1007/s10620-019-05974-z [doi] PST - ppublish SO - Dig Dis Sci. 2020 Aug;65(8):2321-2330. doi: 10.1007/s10620-019-05974-z. Epub 2019 Dec 9.